Portfolio company
Poplar Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops anti-immunoglobulin E antibody therapies to treat patients with food allergies and other atopic conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Tolergyx
This company develops gastrointestinal immunotherapy capsules to treat food allergies in pediatric and adult patients.
Alladapt Immunotherapeutics
This biopharmaceutical company develops oral immunotherapies for patients with single or multiple food allergies to reduce the severity of allergic reactions.
Allegria therapeutics
This company develops therapeutic treatments that modulate mast cell activity for patients suffering from allergic and inflammatory diseases.
Excellergy Therapeutics
This biotechnology company develops trifunctional effector cell response inhibitors to treat patients with severe allergic diseases by removing bound antibodies from immune cells.
Apogee Therapeutics
This biotechnology company develops monoclonal antibody therapies for patients with inflammatory and immunological diseases, including atopic dermatitis, asthma and chronic obstructive pulmonary disease.
Moonlight Therapeutics
This biotechnology company develops microneedle dermal stamps that deliver allergen immunotherapy to patients suffering from peanut and other food allergies.
Aeglea BioTherapeutics
This company develops antibody therapies for patients living with inflammatory bowel disease and other immune-mediated conditions.
Resistentia Pharmaceuticals AB
This company develops immunotherapeutic products for patients suffering from allergic asthma and inflammatory disorders.
